Domperidone, a selective peripheral dopamine receptor antagonist, is a promotility agent. It augments gastrointestinal smooth muscle function in the stomach and small bowel without untoward side effects. We have completed a double-blind randomized study establishing domperidone's efficacy. This symptomatic open-labeled study enables us to treat and to collect extra data on symptomatic patients with delayed gastric emptying, who have not responded or had side effects with Domperidone.
Showing the most recent 10 out of 674 publications